Dinara F Mesitskaya, Zaki Z A Fashafsha, Maria G Poltavskaya, Denis A Andreev, Anna R Levshina, Elizaveta A Sultygova, Daria Gognieva, Petr Chomakhidze, Natalia Kuznetsova, Alexander Suvorov, Sekacheva Marina I, Elena Poddubskaya, Alena Novikova, Aleksandra Bykova, Philipp Kopylov
BACKGROUND: Anti-cancer treatment can be fraught with cardiovascular complications, which is the most common cause of death among oncological survivors. Without appropriate cardiomonitoring during anti-cancer treatment, it becomes challenging to detect early signs of cardiovascular complications. In order to achieve higher survival rates, it is necessary to monitor oncological patients outpatiently after anti-cancer treatment administration. In this regard, we aim to evaluate the efficacy of single-lead ECG remote monitoring to detect cardiotoxicity in cancer patients with minimal cardiovascular diseases after the first cycle of polychemotherapy...
February 2024: IJC Heart & Vasculature